2011
DOI: 10.1007/s10856-011-4326-3
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of decellularized and crosslinked artery patch for vascular tissue-engineering application

Abstract: There is an urgent clinical need of tissue-engineering (TE) vascular grafts, so this study was for developing a fast and simple way of producing TE vascular scaffold. The TE vascular scaffold was prepared with pepsin, DNase and RNase enzymatic decellularization and crosslinked with 0.1, 1, 5% glutaraldehyde (GA), respectively. The samples were underwent analyses of burst pressure; suture strength; cytotoxicity; enzymatic degradation in vitro; degradation in vivo; rehydration; biocompatibilities detected with h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 30 publications
0
9
0
Order By: Relevance
“…Therefore, use of the 3 agents was effective in AF decellularization. Previously, decellularization with Triton X-100 completely removed nuclear material in nerve, pericardium and bone [11], [16][17]; with SDS removed cells in meniscus, cornea and cartilage bone [12], [14], [18]; and with trypsin removed cells in dermal, aortic and aortic valve tissue [13], [15], [19], [21]. However, the cell removal efficacy of Triton X-100 is controversial: nuclear material was observed in tendon, artery, and ligament after decellularization with Triton X-100 solution [26][28].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, use of the 3 agents was effective in AF decellularization. Previously, decellularization with Triton X-100 completely removed nuclear material in nerve, pericardium and bone [11], [16][17]; with SDS removed cells in meniscus, cornea and cartilage bone [12], [14], [18]; and with trypsin removed cells in dermal, aortic and aortic valve tissue [13], [15], [19], [21]. However, the cell removal efficacy of Triton X-100 is controversial: nuclear material was observed in tendon, artery, and ligament after decellularization with Triton X-100 solution [26][28].…”
Section: Discussionmentioning
confidence: 99%
“…Pig AF were incubated under continuous shaking in trypsin/EDTA (0.5% trypsin and 0.2% EDTA; both Sigma) in hypotonic Tris-HCl buffer, together with RNase A (20 µg/ml) and DNase I (0.2 mg/ml) at 37°C for 72 h. The trypsin/EDTA solution was changed every 24 h. Then decellularized AF was washed with PBS for 24 h under shaking for removal of residual substances [19][21].…”
Section: Methodsmentioning
confidence: 99%
“…Notably, there is no absolute method for cartilage sterilization and decellularization. Common methods often include chemicals (e.g., NaOH, H 2 O 2 ) and/or enzymes (e.g., DNase/RNase, pepsin) . Recently, Kang et al reported that 1% Triton X‐100 successfully reduced the DNA content in human nasal septal cartilage, indicating that this protocol may be ideal for the sterilization and decellularization of other types of cartilage .…”
Section: Discussionmentioning
confidence: 99%
“…Common methods often include chemicals (e.g., NaOH, H 2 O 2 ) and/or enzymes (e.g., DNase/ RNase, pepsin). 26,27 Recently, Kang et al reported that 1% Triton X-100 successfully reduced the DNA content in human nasal septal cartilage, indicating that this protocol may be ideal for the sterilization and decellularization of other types of cartilage. 17 Here, we found that 1% Triton X-100-treated porcine auricular cartilage did not express MHC classes I and II antigens and the DNA content was reduced in 99.8% of the samples.…”
Section: Discussionmentioning
confidence: 99%
“…Decellularized scaffold is prepared by eliminating the cellular components from the biological tissue and leaving the extracellular matrix scaffold, which can be used in artificial organ and tissue regeneration . Previous reports have shown that decellularized scaffold has been widely used to engineer vascular graft ; nevertheless, it has not been used to engineer lymphatic graft yet.…”
Section: Introductionmentioning
confidence: 99%